CoChat
Sign Up
Cited by 368

The DOI matches its Crossref record.

Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract

Wentzensen, Nicolas, Vinokurova, Svetlana, Doeberitz, Magnus von Knebel·2004·Cancer Research
DOI 10.1158/0008-5472.can-04-0009
Open this paper in CoChat — free account

Abstract

Cancers of the anogenital tract as well as some head and neck cancers are caused by persistent infections with high-risk type human papillomaviruses (HPVs). Two viral oncogenes, E6 and E7, induce severe chromosomal instability associated with centrosome aberrations, anaphase bridges, chromosome lagging, and breaking. This occurs early in preneoplastic lesions, when the viral genome still persists in an episomal state. In most invasive cancers and also in a few high-grade dysplastic lesions, however, integration of high-risk HPV genomes into the host genome is observed. Integration seems to be a direct consequence of chromosomal instability and an important molecular event in the progression of preneoplastic lesions. Disruption or deregulation of defined critical cellular gene functions by insertional mutagenesis by integrated HPV genome fragments has been hypothesized as one major promoting factor in the pathogenesis of HPV-associated cancers. This hypothesis was based on the detection of HPV integration events in the area of tumor-relevant genes in few cases. Here, we reviewed >190 reported integration loci with respect to changes in the viral structure and the targeted genomic locus. This analysis confirms that HPV integration sites are randomly distributed over the whole genome with a clear predilection for genomic fragile sites. No evidence for targeted disruption or functional alteration of critical cellular genes by the integrated viral sequences could be found.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-0009

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 42

  1. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst (Bethesda), 92: 690-8, 2000. · DOI
  2. Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene, 20: 7874-87, 2001. · DOI
  3. Munger K, Basile JR, Duensing S, et al Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20: 7888-98, 2001. · DOI
  4. Duensing S, Munger K. Centrosome abnormalities, genomic instability and carcinogenic progression. Biochim Biophys Acta, 1471: M81-8, 2001. · DOI
  5. Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol, 65: 606-12, 1991. · DOI · Paper page
  6. Daniel B, Mukherjee G, Seshadri L, Vallikad E, Krishna S. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analyzed by PCR. J Gen Virol, 76(Pt 10): 2589-93, 1995. · DOI
  7. Pirami L, Giache V, Becciolini A. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol (Lond.), 50: 600-4, 1997. · DOI
  8. Durst M, Croce CM, Gissmann L, Schwarz E, Huebner K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA, 84: 1070-4, 1987. · DOI · Paper page
  9. Ferber MJ, Thorland EC, Brink AA, et al Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene, 22: 7233-42, 2003. · DOI
  10. Ferber MJ, Montoya DP, Yu C, et al Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene, 22: 3813-20, 2003. · DOI
  11. Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA, 92: 1654-8, 1995. · DOI
  12. von Knebel Doeberitz M, Bauknecht T, Bartsch D, zur Hausen H. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci USA, 88: 1411-5, 1991. · DOI
  13. Ziegert C, Wentzensen N, Vinokurova S, et al A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene, 22: 3977-84, 2003. · DOI
  14. Butel JS. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis (Lond.), 21: 405-26, 2000. · DOI
  15. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, von Knebel Doeberitz M. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene, 21: 419-26, 2002. · DOI
  16. Reuter S, Bartelmann M, Vogt M, et al APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J, 17: 215-22, 1998. · DOI
  17. Cannizzaro LA, Durst M, Mendez MJ, Hecht BK, Hecht F. Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genet Cytogenet, 33: 93-8, 1988. · DOI
  18. Mincheva A, Gissmann L, zur Hausen H. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol (Berl.), 176: 245-56, 1987. · DOI
  19. Luft F, Klaes R, Nees M, et al Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer, 92: 9-17, 2001. · DOI
  20. Kalantari M, Blennow E, Hagmar B, Johansson B. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol, 10: 46-54, 2001. · DOI
  21. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol, 215: 403-10, 1990. · DOI · Paper page
  22. Geisen C, Delius H, Lichter P, Kahn T. A transcribed human sequence related to the mouse HCl and the human papillomavirus type 18 E5 genes is located at chromosome 7p13-14. Hum Mol Genet, 4: 1337-45, 1995. · DOI
  23. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene, 22: 5938-45, 2003. · DOI · Paper page
  24. Hall AH, Alexander KA. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol, 77: 6066-9, 2003. · DOI
  25. von Knebel Doeberitz M, Rittmuller C, zur Hausen H, Durst M. Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6–E7 anti-sense RNA[letter]. Int J Cancer, 51: 831-4, 1992. · DOI
  26. Yoshinouchi M, Yamada T, Kizaki M, et al In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol Ther, 8: 762-8, 2003. · DOI · Paper page
  27. Sutherland GR, Richards RI. Fragile sites-cytogenetic similarity with molecular diversity. Am J Hum Genet, 64: 354-9, 1999. · DOI
  28. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet, 5: 187-95, 1996. · DOI
  29. Matzner I, Savelyeva L, Schwab M. Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line. Cancer Lett, 189: 207-19, 2003. · DOI
  30. Hopman AH, Smedts F, Dignef W, et al Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol, 202: 23-33, 2004. · DOI
  31. Daniel R, Kao G, Taganov K, et al Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response. Proc Natl Acad Sci USA, 100: 4778-83, 2003. · DOI
  32. Parton A, Grand RJ, Biggs P, Settleman J, DiMaio D, Gallimore PH. Integrated HPV 1 genomes in a human keratinocyte cell line can be transactivated by a SV40/BPV1 recombinant virus which expresses BPV1 E2 proteins. Virology, 175: 508-17, 1990. · DOI
  33. Couturier J, Sastre-Garau X, Schneider-Maunoury S, Labib A, Orth G. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J Virol, 65: 4534-8, 1991. · DOI
  34. Hori T, Ichimura H, Minamihisamatsu M, et al Chromosomal insertion and amplification of human papillomavirus 16 DNA sequences in a cell line of argyrophil small cell carcinoma of the uterine cervix. Jpn J Cancer Res, 82: 371-5, 1991. · DOI
  35. Smith PP, Friedman CL, Bryant EM, McDougall JK. Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines. Genes Chromosomes Cancer, 5: 150-7, 1992. · DOI
  36. Gilles C, Piette J, Ploton D, Doco-Fenzy M, Foidart JM. Viral integration sites in human papilloma virus-33-immortalized cervical keratinocyte cell lines. Cancer Genet Cytogenet, 90: 63-9, 1996. · DOI
  37. Wagatsuma M, Hashimoto K, Matsukura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol, 64: 813-21, 1990. · DOI
  38. Choo KB, Chen CM, Han CP, Cheng WT, Au LC. Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions. J Med Virol, 49: 15-22, 1996. · DOI
  39. Shera KA, Shera CA, McDougall JK. Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells. J Virol, 75: 12339-46, 2001. · DOI
  40. Peitsaro P, Hietanen S, Johansson B, Lakkala T, Syrjanen S. Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage. Carcinogenesis (Lond.), 23: 1057-64, 2002. · DOI
  41. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene, 21: 1510-7, 2002. · DOI
  42. Thorland EC, Myers SL, Gostout BS, Smith DI. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene, 22: 1225-37, 2003. · DOI

Cited by

Metadata

Authors
Wentzensen, N., Vinokurova, S., & Doeberitz, M. V. K.
Venue
Cancer Research
Publisher
American Association for Cancer Research (AACR)
Published
2004-06-01
Volume
64
Issue
11
Pages
3878-3884
ISSN
  • 0008-5472
  • 1538-7445
DOI
10.1158/0008-5472.can-04-0009
Cited by
368
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review